Article 01 Oct 2025 FDA Presses Forward On PDUFA VII CGT Commitments With Release Of Draft Guidance On Clinical Trial Design, Methods For Capturing Postapproval Data United States Healthcare
Article 29 Sep 2025 FDA's Latest On Emergency Diagnostics And A No-Frills Rescission Of The LDT Rule United States Healthcare
Article 16 Sep 2025 From Foods To Pharmaceuticals, MAHA Strategy Offers Broad Menu Of FDA Actions United States Healthcare
Article 10 Sep 2025 FDA Continues Focus On Rare Disease Drug Development, Announces Evidence Principles United States Healthcare
Article 04 Sep 2025 Five Health Care Issues To Watch As Congress Returns From August Recess United States Healthcare
Article 28 Aug 2025 OMUFA Reauthorization On Deck As Congress Returns From Recess United States Healthcare
Article 08 Jul 2025 Republicans Pass The One Big Beautiful Bill Act Ahead Of The July 4 Deadline United States Strategy
Article 25 Jun 2025 FDA Announces Commissioner's National Priority Voucher Program To Accelerate Drug Application Review Process And Support National Priorities United States Healthcare
Article 09 Jun 2025 No Appeal Of LDT Decision Means Ball Is Back In FDA's Court For Policy Clarification United States Healthcare
Article 27 May 2025 MAHA Commission Report On Children's Health Takes Aim At Ultra-Processed Foods And Medication Practices, Among Other Targets United States Healthcare
Article 21 May 2025 The Trump Administration Continues Focus On Drug Pricing With "Most-Favored-Nation Prescription Drug Pricing" Executive Order United States Healthcare
Article 09 May 2025 The Trump Administration Seeks To Spur Domestic Drug Manufacturing With Regulatory Relief EO United States Healthcare
Article 23 Apr 2025 The Trump Administration Turns To Drug Pricing: Key Actions And Timelines Under The New EO United States Healthcare
Article 05 Apr 2025 District Court Vacates FDA LDT Rule; What's Next For Regulation Of Lab Testing? United States Healthcare